Skip to main content

Table 3 Clinicopathological details

From: Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: a cohort study

Parameters

 

Number (%)

Porphyromonas gingivalis

P value

Low

High

Age (years)

55.8 ± 12.7

95 (100)

55.7 ± 12.6

56.5 ± 14.6

0.860

Gender

Male

65 (68.4)

57

8

0.999

Female

30 (31.6)

27

3

 

Systemic disease

No

69 (72.6)

61

8

0.999

Yes

26 (27.4)

23

3

 

Pathologic staging

pStage I + II

69 (72.6)

65

4

0.008

pStage III + IV

26 (27.4)

19

7

 

Smoking

No

45 (47.4)

39

6

0.612

Yes

50 (52.6)

45

5

 

Alcohol consumption

No

57 (60.0)

50

7

0.999

Yes

38 (40.0)

34

4

 

Location

Buccal

21 (24.2)

21

2

0.447

Tongue

52 (54.7)

47

5

 

Gingiva

11 (11.6)

9

2

 

Floor of mouth

5 (5.3)

4

1

 

Hard palate

4 (4.2)

3

1

 

Differentiation grade

Well

17 (19.1)

16

1

0.735

Moderate

65 (73.0)

57

8

 

Poor

7 (7.9)

6

1

 

FimA genotypes

I + Ib

20 (21.1)

17

3

0.795*

II

30 (31.6)

27

3

 

III

4 (4.2)

4

0

 

IV

20 (21.1)

16

4

 

V

2 (2.1)

2

0

 

I + Ib + II

1 (1.1)

1

0

 

I + Ib + III

2 (2.1)

2

0

 

I + Ib + IV

1 (1.1)

1

0

 

I + Ib + V

1 (1.1)

1

0

 

II + IV

3 (3.2)

3

0

 

I + Ib + II + IV

1 (1.1)

1

0

 

Untyped

10 (10.5)

9

1

 

Treatment†

Surgery

64 (68.1)

60

4

–

Surgery + RT or CRT**

30 (31.9)

23

7

 

Outcome†

Recurrence

24 (25.5)

25

0

0.033

Disease-free

70 (74.5)

58

11

 

Disease-free time (months)

23, 10

94 (98.9)

22, 13.8

27, 8

0.029

  1. *Chi-square test was used among fimA genotype I + Ib, II, III, IV, V
  2. †One patient dropped out in follow-up
  3. **RT: Radiotherapy, CRT: Chemo-radiotherapy